Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer

Oncology Reports
Jisu OhNam Keun Kim

Abstract

The microRNA (miR)-34 family is a direct transcriptional target of tumor-suppressor TP53 and loss of miR-34 function may impair TP53-mediated cell cycle arrest and apoptosis. In the present study, we investigated whether the single nucleotide polymorphisms (SNPs) rs4938723 (T>C) in the promoter region of miR-34b/c and Arg72Pro (G>C) in codon 72 of TP53 are independently or complementarily associated with the risks and clinical outcomes of colorectal cancer (CRC) and whether the combined effect of these SNPs and metabolic risk factors are related to CRC. We evaluated the SNPs in 545 CRC patients and 428 healthy controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequence analysis. We found that the GC and GC/CC genotypes of TP53 Arg72Pro were associated with decreased risk of CRC (adjusted OR = 0.727 for GC; OR = 0.735 for GC/CC). The combined genotypes of TT-GC and CC-GG were significantly associated with reduced CRC risk (adjusted OR = 0.628 for TT-GC; OR = 0.381 for CC-GG, respectively). The SNP rs4938723 and diabetes mellitus (DM) together were associated with an increased CRC risk, but the SNP TP53 Arg72Pro CC with DM showed a protective effect against CRC. These findings ind...Continue Reading

References

Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Nov 26, 2002·Cancer Letters·Yoshiki KurodaTakahiko Katoh
Feb 5, 2003·Nature Genetics·Patrick DumontMaureen Murphy
Jun 26, 2003·Journal of Biomedical Science·Kazuhiro SuzukiHidetoshi Yamanaka
Sep 17, 2004·Nature·Gunter Meister, Thomas Tuschl
Apr 19, 2005·American Journal of Human Genetics·Jacqueline K Wittke-ThompsonNancy J Cox
May 11, 2005·Biochemical and Biophysical Research Communications·Naoharu Iwai, Hiroaki Naraba
May 25, 2006·Cancer·Rehana L AhmedAaron R Folsom
Jan 2, 2007·Trends in Cell Biology·Ramesh S PillaiWitold Filipowicz
Feb 20, 2007·Cancer Research·Amaia LujambioManel Esteller
Jun 2, 2007·Molecular Cell·Tsung-Cheng ChangJoshua T Mendell
Jun 8, 2007·Nature·Lin HeGregory J Hannon
Jul 28, 2007·Current Biology : CB·Guido T BommerEric R Fearon
Nov 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lanlan ShenJean-Pierre J Issa
Dec 19, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alireza Ansary MoghaddamRachel Huxley
Jun 10, 2008·Cardiovascular Research·Francesco Fazi, Clara Nervi
Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amaia LujambioManel Esteller
Oct 3, 2009·Journal of Cellular Physiology·Jonathan ChouZena Werb
Jul 10, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Issa J DahabrehSamuel Murray
Nov 5, 2011·International Journal of Cancer. Journal International Du Cancer·Eri HirokiNobuo Yaegashi
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 22, 2012·EMBO Molecular Medicine·Marilena V Iorio, Carlo M Croce
Jun 2, 2012·The Lancet Oncology·Yi W KongMartin Bushell
Oct 24, 2012·Frontiers in Genetics·Sonja Hrašovec, Damjan Glavač

❮ Previous
Next ❯

Citations

Dec 6, 2014·Clinics and Research in Hepatology and Gastroenterology·Qi LiuGe Shi
Feb 7, 2015·Genetic Testing and Molecular Biomarkers·Xin-Min PanLin-Bo Gao
Sep 6, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaowei LiJiajun Du
Sep 10, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·De-Hui YiYong-Feng Liu
Aug 4, 2015·Pharmacogenomics·Elena Puerta-GarcíaMiguel Ángel Calleja-Hernández
Sep 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Tian-Xing JiFei-Fei Ma
Sep 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Zhuo LinKai-Fu Tang
Oct 20, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Xinjing WangBaiyong Shen
May 20, 2017·Oncology Letters·Guo-Qiang RongWei Gong
Dec 2, 2015·Infectious Agents and Cancer·Gabriela Elizabeth Campos-ViguriGloria Fernández-Tilapa
Apr 24, 2020·Scientific Reports·Soon-Chan KimJa-Lok Ku
Dec 2, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fang YuanLinbo Gao
Mar 19, 2021·Pharmacogenomics·Amirsaeed Sabeti AghabozorgiMohammad Reza Abbaszadegan
Jun 7, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Soudeh Ghafouri-FardMohammad Taheri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis